June 2026– date –
-
New Technology
bioRxiv: APOSM Improves Generative Small-Molecule Design via Pairwise Preference Learning, Accelerating Lead Optimization
bioRxiv USA Overview A bioRxiv preprint introduces APOSM, an active-learning algorithm that enhances generative small-molecule design by employing pairwise preference learning for surrogate models, moving beyond absolute scores. This met... -
Drug Discovery & DDS
ABL Bio’s Bispecific EGFR/MUC1 ADC, ABL209, Progresses in US Phase 1 Trial, Preclinical Data Presented at World ADC Korea
Seoul Economic Daily South Korea Overview ABL Bio unveiled preclinical data for its bispecific ADC candidate, ABL209 (NEOK002), currently in US Phase 1 clinical trials, at the 5th World ADC South Korea 2026. ABL209 targets both EGFR and ... -
New Technology
AI/Machine Learning Drives Target Identification and Precision Nanomedicine in Drug Discovery, Enhancing Candidate Selection and Pathway Analysis
Dove Medical Press USA Overview Machine learning (ML) and deep learning (DL) strategies are advancing drug discovery by enhancing target identification and precision nanomedicine. These technologies leverage virtual screening and bioacti... -
New Technology
Integrating AI and Nodal Biology Accelerates Cell Response Prediction, Building Future Drug Discovery Engine
amacad.org USA Overview The integration of artificial intelligence with "nodal biology" is poised to revolutionize drug discovery by accelerating target identification through predicting human cellular responses to disease perturbations.... -
New Technology
AlphaFold and AlphaFold 3 Revolutionize Protein Structure and Interaction Prediction, Significantly Accelerating Drug Discovery
IntuitionLabs / dev.to USA Overview AlphaFold and its successor, AlphaFold 3, are dramatically advancing protein structure and molecular interaction prediction, significantly compressing traditional drug discovery timelines. AlphaFold 3 ... -
New Technology
FDA Approves Oral Peptide Icorokinra for Moderate-to-Severe Plaque Psoriasis, Driven by Advanced DDS
Dermatology Times USA Overview The FDA has approved icorokinra, the first oral IL-23 receptor antagonist peptide for moderate-to-severe plaque psoriasis, representing a significant breakthrough in oral peptide delivery systems (DDS). Thi... -
Solid-State Batteries
24ChemicalResearch Report Forecasts High-Nickel Cathodes to Dominate Long-Range EVs in 2026 Battery Market
24ChemicalResearch Unknown Overview This article is an overview of a market research report issued by 24ChemicalResearch. The report forecasts that high-nickel cathodes will continue to dominate the premium and long-range vehicle categor... -
Solid-State Batteries
Solidion Technology Granted 7 New U.S. Patents for Composite Anode Materials Targeting Humanoid Robots, Space-Based AI Data Centers, and the Lunar Economy
PR Newswire USA Overview Solidion Technology Inc. announced it has been granted seven new U.S. patents for composite anode materials, bringing its total U.S. anode technology portfolio to 130 patents. These patents target batteries for h... -
Solid-State Batteries
U.S. Tech Briefs Announces New Gel Electrolyte for Multi-Layer Anode-Free Pouch Cells with Enhanced High-Temperature Stability and Abuse Tolerance
Tech Briefs USA Overview Researchers have developed a new gel electrolyte for multi-layer anode-free pouch cells, demonstrating significant improvements in high-temperature stability and surviving severe abuse tests (intense drilling) wi... -
Solid-State Batteries
Svenner’s Novel Solid-State Battery Withstands Extreme Abuse, Paving Way for Safer Marine Electrification
Matt Sheahan デンマーク Overview Danish firm Svenner has unveiled a novel all-solid-state battery system capable of withstanding extreme abuse, including 6x overcharge and 8mm nail penetration, without any thermal response. By replacing ...